1. UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, DC 20549 Form 10-K⌧ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934for…

H A R L E YD A V I D S O NI N C F O R M1 0 - K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-K For the fiscal year ended:…

1. for our customers, shareholders, employees and stakeholders2005 Annual Report 2. Creating Value In 2005, we continued to accelerate Celanese toward greater growth and…

1. Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Form 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES…

1. UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, DC 20549Form 10-K/AAmendment No. 1 ¥ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE…

1. UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, DC 20549 Form 10-K ¥ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For…

1. What You Need to Know about the Drug Quality Security Act (DQSA) By LauraM. Olson DirectorofSales and Marketing InitialImplementation Phases 2. DQSA Policy Background…

1. UNITED STATESSECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-K (Mark One)≤ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT…

1. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT…

1. UNITED STATESSECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One)ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGEACT…